title: Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
authors.forename: M
authors.initials: M
authors.lastname: Kawabata
authors.forename: S
authors.initials: S
authors.lastname: Kasuga
authors.forename: H
authors.initials: H
authors.lastname: Hara
authors.forename: S
authors.initials: S
authors.lastname: Suyama
authors.forename: K
authors.initials: K
authors.lastname: Moriyama
authors.forename: T
authors.initials: T
authors.lastname: Takabatake
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D002331:Carnitine / Q000008:administration & dosage*; D018450:Disease Progression; D004351:Drug Resistance; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D002331:Carnitine